Cell Signaling Technology

Product Pathways - Apoptosis / Autophagy

AP-2α (C83E10) Rabbit mAb #3215

Applications Reactivity MW (kDa) Source Isotype
W IF-IC H M R Mk 48 Rabbit IgG

Applications Key:  W=Western Blotting  IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
Species enclosed in parentheses are predicted to react based on 100% sequence homology. Species cross-reactivity is determined by Western blot.

Specificity / Sensitivity

AP-2α (C83E10) Rabbit mAb detects endogenous levels of total AP-2α protein.

Source / Purification

Monoclonal antibody is produced by immunizing rabbits with a synthetic peptide (KLH-coupled) derived from human AP-2α.

Western Blotting

Western Blotting

Western blot analysis of extracts from various cell types using AP-2α (C83E10) Rabbit mAb.

IF-IC

IF-IC

Confocal immunofluorescent analysis of HeLa cells using AP-2α (C83E10) Rabbit mAb (green). Actin filaments have been labeled with DY-554 phalloidin (red).

Background

The sequence-specific transcription factor activator protein 2α (AP-2α) is required for normal growth and morphogenesis during mammalian development (1,2). Decreased or loss of AP-2α expression has been observed in many different types of human cancers including breast cancer (3,4), ovarian cancer (5), melanoma (6) and prostate cancer (7). These findings suggest that AP-2α expression plays a crucial role in tumorigenicity. Studies have also shown that p53 overexpression in human breast carcinoma cells induces the level of AP-2α expression. Furthermore, p53 binds to the cis-element in the AP-2α promoter, suggesting that AP-2α is a target of p53. AP-2α may mediate the effect of p53 to inhibit cell proliferation (8).

  1. Mitchell, P.J. et al. (1987) Cell 50, 847-61.
  2. Williams, T. and Tjian, R. (1991) Genes Dev 5, 670-82.
  3. Douglas, D.B. et al. (2004) Cancer Res 64, 1611-20.
  4. Gee, J.M. et al. (1999) J Pathol 189, 514-20.
  5. Anttila, M.A. et al. (2000) Br J Cancer 82, 1974-83.
  6. Jean, D. et al. (1998) J Biol Chem 273, 16501-8.
  7. Ruiz, M. et al. (2004) Cancer Res 64, 631-8.
  8. Li, H. et al. (2006) Oncogene 25, 5405-15.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes